AMICUS THERAPEUTICS, INC. Annual Operating Margin in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Amicus Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2023.
  • Amicus Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was 1.06 %.
  • Amicus Therapeutics, Inc. annual Operating Margin for 2023 was -19.3 %, a 70% increase from 2022.
  • Amicus Therapeutics, Inc. annual Operating Margin for 2022 was -64.4 %, a 4.65% increase from 2021.
  • Amicus Therapeutics, Inc. annual Operating Margin for 2021 was -67.6 %, a 28.6% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -19.3 +45.1 +70% Jan 1, 2023 Dec 31, 2023
2022 -64.4 +3.14 +4.65% Jan 1, 2022 Dec 31, 2022
2021 -67.6 +27.1 +28.6% Jan 1, 2021 Dec 31, 2021
2020 -94.7 +72.2 +43.3% Jan 1, 2020 Dec 31, 2020
2019 -167 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.